BaroPace Inc.
BaroPace is a medical technology company focused on revolutionizing cardiac pacing by regulating pacemakers in response to real-time blood pressure measurements. Their mission is to improve treatment for high blood pressure, heart failure, and reduce healthcare costs worldwide through innovative, physiologic pacemaker regulation. The company aims to provide more physiologic pacemaker responses, new treatments for drug resistant hypertension and HFpEF, and expand indications for pacemakers, potentially increasing market share.
Industries
Nr. of Employees
small (1-50)
Patents
Intelligently, continuously and physiologically controlled pacemaker and method of operation of the same
US-12427321-B2
View Details
Intelligently, continuously and physiologically controlled pacemaker and method of operation of the same
US-12427321-B2
View DetailsProducts
Closed-loop blood-pressure-regulated pacemaker control system
A system architecture combining an external blood pressure measurement device, a secure application containing an algorithm that computes optimal right atrial pacing rate, and a communication link that transmits authenticated commands to a dual-chamber pacemaker to adjust pacing in real time.
Medical-grade wearable blood pressure sensor prototype
A cuffless wearable bracelet sensor under co-development capable of acquiring frequent medical-grade blood pressure readings for integration with closed-loop pacing algorithms; prototype planned for clinical validation and regulatory testing.
Closed-loop blood-pressure-regulated pacemaker control system
A system architecture combining an external blood pressure measurement device, a secure application containing an algorithm that computes optimal right atrial pacing rate, and a communication link that transmits authenticated commands to a dual-chamber pacemaker to adjust pacing in real time.
Medical-grade wearable blood pressure sensor prototype
A cuffless wearable bracelet sensor under co-development capable of acquiring frequent medical-grade blood pressure readings for integration with closed-loop pacing algorithms; prototype planned for clinical validation and regulatory testing.
Services
Design and conduct of retrospective analyses and prospective early-feasibility and first-in-human multi-center trials evaluating blood-pressure-regulated pacing systems, including IRB coordination and endpoint assessment.
Bench-top engineering and prototype development of integrated systems combining blood pressure measurement devices, application/algorithm software, and pacemaker interfaces for preclinical and clinical evaluation.
Development and validation of algorithms and AI models to translate real-time physiologic inputs into safe, optimized pacing commands with built-in safety subroutines and patient interaction features.
Design and conduct of retrospective analyses and prospective early-feasibility and first-in-human multi-center trials evaluating blood-pressure-regulated pacing systems, including IRB coordination and endpoint assessment.
Bench-top engineering and prototype development of integrated systems combining blood pressure measurement devices, application/algorithm software, and pacemaker interfaces for preclinical and clinical evaluation.
Development and validation of algorithms and AI models to translate real-time physiologic inputs into safe, optimized pacing commands with built-in safety subroutines and patient interaction features.
Expertise Areas
- Clinical trial management for medical devices
- Implantable cardiac device control systems
- Physiologic algorithm and AI modeling
- Wearable blood pressure sensor integration
Key Technologies
- Closed-loop control algorithms for medical devices
- AI/ML modeling for physiologic control
- Bluetooth wireless communication for medical devices
- Wearable cuffless blood pressure sensing
News & Updates
BaroPace Inc announces first enrollment in its First-in-Human multi-center clinical trial in India, RelieveHFpEF-II.
BaroPace received approval to proceed with its first prospective multi-site clinical trial, the Chairside I, v1 Study.
BaroPace issued a press release announcing Michael Coyle's addition to the company's board.
AI modeling to complete a fully autonomous PressurePace™ algorithm and closed loop system.
BaroPace Inc announces first enrollment in its First-in-Human multi-center clinical trial in India, RelieveHFpEF-II.
BaroPace received approval to proceed with its first prospective multi-site clinical trial, the Chairside I, v1 Study.
BaroPace issued a press release announcing Michael Coyle's addition to the company's board.
AI modeling to complete a fully autonomous PressurePace™ algorithm and closed loop system.